Vertical Vet, Titan Group partner to boost controlled substance complianceSeptember 17, 2018Titan Group now offers Drug Enforcement Administration (DEA) controlled substances solutions to new and existing Vertical Vet members. The partnership provides exclusive access to Titan's suite of services, designed to reduce risk, remediate issues, and educate personnel on how to prepare for DEA audits and inspections as well as prevent and detect internal and external drug diversion activity, according to Titan. "Our goal is to provide the veterinary industry with proactive controlled substances compliance solutions that are easy to implement and sustain long term," said Jack Teitelman, Titan founder and CEO. "Every veterinary practice handling controlled substances is at risk for noncompliance. Inadequate security and failure to prevent drug diversion can cost a practice in lost inventory, damage to reputation, and potential physical harm to staff and patients. In the current world of widespread opioid abuse, both internal and external drug diversion threats are continuing to increase. Sadly, many unsuspecting practices remain in the dark until their drugs are stolen or missing." In addition, the partnership offers exclusive discounts on DEA risk inspections and audits to members. Access to educational resources, including webinars, industry-accredited CLE courses, and compliance training modules, also are available as part of the partnership. "We …
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
